Powder: -20°C for 3 years | In solvent: -80°C for 1 year
TLR7/8 agonist 4 hydroxy-PEG10-acid (compound 9) is a drug-linker conjugate employed in antibody-drug conjugates (ADC). This compound exhibits remarkable antitumor activity by utilizing TLR7/8 agonist 4, which acts as a potent activator of TLR7/8. The TLR7/8 agonist 4 is linked to hydroxy-PEG10-acid, the ADC linker, via a cleavable bond. Overall, it demonstrates promising pharmaceutical potential in the context of ADC-based therapeutics.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
100 mg | Inquiry | Inquiry | |
500 mg | Inquiry | Inquiry |
Description | TLR7/8 agonist 4 hydroxy-PEG10-acid (compound 9) is a drug-linker conjugate employed in antibody-drug conjugates (ADC). This compound exhibits remarkable antitumor activity by utilizing TLR7/8 agonist 4, which acts as a potent activator of TLR7/8. The TLR7/8 agonist 4 is linked to hydroxy-PEG10-acid, the ADC linker, via a cleavable bond. Overall, it demonstrates promising pharmaceutical potential in the context of ADC-based therapeutics. |
In vitro | ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker. |
Synonyms | TLR7/8 agonist 4 hydroxy-PEG10-acid |
Molecular Weight | 837.025 |
Formula | C41H68N6O12 |
CAS No. | 2388520-17-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
TLR7/8 agonist 4 hydroxy-PEG10-acid 2388520-17-8 TLR7/8 agonist 4 hydroxy PEG10 acid TLR7/8 agonist 4 hydroxyPEG10acid TLR-7/8 agonist 4 hydroxy-PEG10-acid inhibitor inhibit